Skip to content

Product information

Kaletra 200 mg - 50 mg
120
lopinavir + ritonavir
2270361
0.88 / 10
Locked

Product properties

192725-17-0
J05AR10
AbbVie Deutschland
Film-coated tablet
€273.78
EU/1/01/172/004
08054083016276, 08054083027043
M42
Public
284487-01

Pharmacist Assessment

Chronically unavailable product

This product is officially available but is structurally not or barely supplied (current score 0.88/10, historical score 🔒/10). Consider using a structural alternative.

Recommended alternative

Different strength — dose adjustment required. Consult the physician.
Note: commercialization of this product will be stopped on 01/07/2027.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 2 of 18 warehouse locations have stock
  • 1 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Planned
From 01/07/2027

Commercial reasons

Adaptation of the treatment is possible
Available Active
Until 30/06/2027

Composition

4 ingredients

Substance Type Strength CAS
Active ingredient
50 mg
155213-67-5
Active ingredient
200 mg
192725-17-0
Excipient
Excipient

Additional information

Availability statistics

Available
0 days
2
0